BEUDAMED
    FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

    Stent, Superficial Femoral Artery, Drug-Eluting

    PMA: P100022 · Supplement: S045 · Decision Mar 25, 2026
    View on FDA
    Classifications
    1
    FEI Numbers
    0
    Registration Numbers
    0

    Basic Information

    Device Name
    Stent, Superficial Femoral Artery, Drug-Eluting
    Trade Name
    Zilver® PTX® Drug-Eluting Peripheral Stent
    PMA Number
    P100022
    Supplement Number
    S045
    Device Class
    FDA Class 3
    Product Code
    NIU
    Generic Name
    Stent, superficial femoral artery, drug-eluting
    Medical Specialty
    Unknown
    Advisory Committee
    Cardiovascular
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    March 25, 2026
    Date Received
    March 2, 2026
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    an approval for a change in the annual monitoring stability study sampling plan

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    NIU Stent, Superficial Femoral Artery, Drug-Eluting